Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) hit a new 52-week low during trading on Monday . The company traded as low as $14.01 and last traded at $14.01, with a volume of 1911 shares changing hands. The stock had previously closed at $14.63.
Analysts Set New Price Targets
TLX has been the topic of a number of recent research reports. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research report on Tuesday, November 19th. UBS Group initiated coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They set a "buy" rating and a $21.00 target price on the stock.
Read Our Latest Stock Analysis on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Trading Down 0.5 %
The stock's 50-day simple moving average is $15.61.
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Stories
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
